Actinium Pharmaceuticals Inc (ATNM)
6.83
+0.27
(+4.12%)
USD |
NYAM |
Apr 26, 12:44
Actinium Pharmaceuticals Free Cash Flow (Quarterly): -7.49M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -7.49M |
| September 30, 2023 | -11.16M |
| June 30, 2023 | -13.69M |
| March 31, 2023 | -15.15M |
| December 31, 2022 | -7.794M |
| September 30, 2022 | -5.788M |
| June 30, 2022 | 27.65M |
| March 31, 2022 | -5.788M |
| December 31, 2021 | -5.052M |
| September 30, 2021 | -5.656M |
| June 30, 2021 | -4.645M |
| March 31, 2021 | -5.646M |
| December 31, 2020 | -6.503M |
| September 30, 2020 | -5.002M |
| June 30, 2020 | -4.511M |
| March 31, 2020 | -5.854M |
| December 31, 2019 | -5.016M |
| September 30, 2019 | -5.598M |
| June 30, 2019 | -5.372M |
| March 31, 2019 | -5.54M |
| December 31, 2018 | -4.298M |
| September 30, 2018 | -6.673M |
| June 30, 2018 | -4.231M |
| March 31, 2018 | -5.466M |
| December 31, 2017 | -3.170M |
| Date | Value |
|---|---|
| September 30, 2017 | -5.877M |
| June 30, 2017 | -7.148M |
| March 31, 2017 | -5.383M |
| December 31, 2016 | -4.258M |
| September 30, 2016 | -5.571M |
| June 30, 2016 | -6.236M |
| March 31, 2016 | -4.784M |
| December 31, 2015 | -3.985M |
| September 30, 2015 | -3.525M |
| June 30, 2015 | -5.268M |
| March 31, 2015 | -5.813M |
| December 31, 2014 | -5.048M |
| September 30, 2014 | -4.262M |
| June 30, 2014 | -2.698M |
| March 31, 2014 | -2.493M |
| December 31, 2013 | -1.353M |
| September 30, 2013 | -1.627M |
| June 30, 2013 | -1.016M |
| March 31, 2013 | -2.313M |
| December 31, 2012 | -1.418M |
| September 30, 2012 | -1.934M |
| June 30, 2012 | -0.9143M |
| March 31, 2012 | -0.9491M |
| December 31, 2011 | -0.5225M |
| September 30, 2011 | 0.00 |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-15.15M
Minimum
Mar 2023
27.65M
Maximum
Jun 2022
-5.161M
Average
-5.656M
Median
Sep 2021
Free Cash Flow (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -9.097M |
| Eli Lilly and Co | -1.963B |
| Cellectar Biosciences Inc | -9.862M |
| Bristol-Myers Squibb Co | 3.922B |
| Oragenics Inc | -1.102M |